Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990737 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
A Phase 2 study of Cutaneous Squamous Cell Carcinoma of the Head and Neck and Clinically Node-Negative (cN0), sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06990737 is a Phase 2 study of Cutaneous Squamous Cell Carcinoma of the Head and Neck and Clinically Node-Negative (cN0) that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06990737, a Phase 2 study of Cutaneous Squamous Cell Carcinoma of the Head and Neck and Clinically Node-Negative (cN0), is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to evaluate the efficacy of SLNB based on the DFS rate at 2 years post-definitive therapy.
Conditions Studied
Interventions
- PROCEDURE Sentinel lymph node biopsy (SLNB)
- PROCEDURE Lymphadenectomy
- DRUG Adjuvant Definitive Therapy
Study Locations (1)
California
- University of California, Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2032-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06990737
The ClinicalTrials.gov registry entry for NCT06990737 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cutaneous Squamous Cell Carcinoma of the Head and Neck appearing as the primary indexed condition, and to 3 interventions - of which Sentinel lymph node biopsy (SLNB) is the first listed.
NCT06990737 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06990737 about?
NCT06990737 is a clinical study titled "Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck". This is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to evaluate the efficacy of SLNB based on the DFS rate at 2 years post-definitive therapy.
What is the current status of trial NCT06990737?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2025-06-25. Estimated completion is 2032-08-01.
What conditions does trial NCT06990737 study?
This clinical trial studies the following conditions: Cutaneous Squamous Cell Carcinoma of the Head and Neck, Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck.
What interventions are being tested in trial NCT06990737?
The interventions under investigation include: Sentinel lymph node biopsy (SLNB) (PROCEDURE), Lymphadenectomy (PROCEDURE), Adjuvant Definitive Therapy (DRUG).
Who is sponsoring clinical trial NCT06990737?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06990737 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Cutaneous Squamous Cell Carcinoma of the Head and Neck
All registered trials for this condition
Clinically Node-Negative (cN0)
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.